Contraceptive implants and efavirenz-based ART: friend or foe?
Morroni, C.; Bekker, L.-G.; Rees, H.
LANCET. HIV 2(11): E454-E455
2015
ISSN/ISBN: 2352-3018 PMID: 26520921 DOI: 10.1016/s2352-3018(15)00204-0Document Number: 293564
Document emailed within 0-6 h
Related Documents
Morroni, C.; Bekker, L.-G.; Rees, H. 2015: Contraceptive implants and efavirenz-based ART: friend or foe? LANCET. HIV 2(11): E454-E455Shelton, J.D. 2015: Reduced Effectiveness of Contraceptive Implants for Women Taking the Antiretroviral Efavirenz (EFV): Still Good Enough and for how Long? Global Health Science and Practice 3(4): 528-531
Scarsi, K.; Lamorde, M.; Darin, K.; Penchala, S.D.; Else, L.; Nakalema, S.; Byakika-Kibwika, P.; Khoo, S.; Cohn, S.; Merry, C.; Back, D. 2014: Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implant Journal of the International Aids Society 17(4 Suppl 3: 19484
Patel, R.C.; Onono, M.; Gandhi, M.; Blat, C.; Hagey, J.; Shade, S.B.; Vittinghoff, E.; Bukusi, E.A.; Newmann, S.J.; Cohen, C.R. 2015: Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study Lancet. HIV 2(11): E474-E482
Maleewong, U.; Kulsomboon, V.; Teerawattananon, Y. 2008: The cost-effectiveness analysis of initiating HIV/AIDS treatment with efavirenz-based regimens compared with nevirapine-based regimens in Thailand Journal of the Medical Association of Thailand 91(Suppl 2): S126-S138
Leticee, N.; Viard, J.-P.; Yamgnane, A.; Karmochkine, M.; Benachi, A. 2012: Contraceptive failure of etonogestrel implant in patients treated with antiretrovirals including efavirenz Contraception 85(4): 425-427
Vasconcelos-Allende, M.; Unda-Ugalde, J.M. 1996: Levonorgestrel contraceptive implants. Facts and controversies of a current contraceptive method Ginecologia y Obstetricia de Mexico 64: 498-502
Vasconcelos-Allende, M.; Unda-Ugalde, J.M. 1996: Levonorgestrel contraceptive implants. Facts and controversies of a current contraceptive method Ginecologia y Obstetricia de Mexico 64: 498-502
Thompson, K.M.J.; Rocca, C.H.; Stern, L.; Morfesis, J.; Goodman, S.; Steinauer, J.; Harper, C.C. 2018: Training contraceptive providers to offer intrauterine devices and implants in contraceptive care: a cluster randomized trial American Journal of Obstetrics and Gynecology 218(6): 597.E1-597.E7
Bisio, F.; Nicco, E.; Calzi, A.; Giacobbe, D.R.; Mesini, A.; Banguissa, H.; Vividila, N.E.; Mahoungou, P.él.; Boumba, J.D.; Mboungou, F.A.M.; Bruzzone, B.; Ratto, S.; Icardi, G.; Viscoli, C.; Bruzzi, P. 2015: Pregnancy outcomes following exposure to efavirenz-based antiretroviral therapy in the Republic of Congo New Microbiologica 38(2): 185-192
Kiertiburanakul, S.; Sungkanuparph, S.; Rattanasiri, S.; Manosuthi, W.; Vibhagool, A.; Thakkinstian, A. 2006: Virological and immunological responses of efavirenz-based HAART regimen initiated in HIV-infected patients at CD4 < 100 versus CD4 > or = 100 cells/mm3 Journal of the Medical Association of Thailand 89(9): 1381-1387
Canestri, A.; Sow, P.S.; Vray, M.; Ngom, F.; M'boup, S.; Kane, C.T.; Delaporte, E.; Gueye, M.é; Peytavin, G.; Girard, P.M.; Landman, R. 2007: Poor efficacy and tolerability of stavudine, didanosine, and efavirenz-based regimen in treatment-naive patients in Senegal Medgenmed: Medscape General Medicine 9(4): 7
Bera, E.; McCausland, K.; Nonkwelo, R.; Mgudlwa, B.; Chacko, S.; Majeke, B. 2010: Birth defects following exposure to efavirenz-based antiretroviral therapy during pregnancy: a study at a regional South African hospital Aids 24(2): 283-289
Coovadia, A.; Abrams, E.J.; Strehlau, R.; Shiau, S.; Pinillos, F.; Martens, L.; Patel, F.; Hunt, G.; Tsai, W.-Y.; Kuhn, L. 2015: Efavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa: a Randomized Clinical Trial JAMA 314(17): 1808-1817
Aguillaume, C.J.; Sivin, I.; Bardin, C.W. 1994: Les implants Norplant® : la première génération de contraceptifs sous-cutanés féminins - Norplant implants: the first generation of female subdermal contraceptive References en Gynecologie Obstetrique 2(3): 268-280
Van Dijk, J.H.; Sutcliffe, C.G.; Hamangaba, F.; Bositis, C.; Watson, D.C.; Moss, W.J. 2013: Effectiveness of efavirenz-based regimens in young HIV-infected children treated for tuberculosis: a treatment option for resource-limited settings PLOS one 8(1): E55111
Ito, K.E.; Brown, J.D. 2010: To friend or not to friend: using new media for adolescent health promotion North Carolina Medical Journal 71(4): 367-372
Ralisata Ravolamanana, L.; Randaoharison, P.G.; Razafintsalama, D.L. 2000: La contraception par les implants sous-cutanes de Lévonorgestrel (Norplant®) au CHU de Mahajanga Madagascar : Résultats préliminaires - Subcutaneous contraceptive implants of levonorgestrel (Norplant®) in Mahajanga Universitary Hospital - Malagasy republic. Preliminary results Medecine d'Afrique Noire 47(10): 410-415
Croxatto, H.B.; Díaz, S.; Sivin, I. 1991: Contraceptive implants Annals of the new York Academy of Sciences 626: 22-29
Ward, S.; Long, M. 2004: Should under-16s have contraceptive implants? Nursing Times 100(27): 21